Prasugrel Or Ticagrelor In ST-Elevation Myocardial Infarction Patients With Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 08 Aug 2017
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms RESET2D
- 08 Aug 2017 Results published in the Circulation Journal.
- 08 Aug 2016 Status changed from not yet recruiting to completed.
- 19 Apr 2013 Planned End Date changed from 1 Aug 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.